Results 261 to 270 of about 97,874 (341)
Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen +18 more
wiley +1 more source
Enhancing Clinical Full-Field Electroretinograms by Reducing Powerline Noise Using Pre-Amplified Electrodes. [PDF]
Man TTC, Yip YWY, Pang CP, Brelén ME.
europepmc +1 more source
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
Dual-Electrodes PMUTs on Glasses for Wearable Human Blink Monitoring. [PDF]
Liang XX, Wu H, Wang Y.
europepmc +1 more source
Analysis of Operational Amplifier Susceptibility to Multifrequency Disturbance
Alexandre Boyer, Fabrice Caignet
openalex +2 more sources
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic +6 more
wiley +1 more source
Frequency-Stable Low-Threshold SBS-OEO for Precision Temperature Sensing in Electromagnetically Harsh Environments. [PDF]
Teng Y, Yang M, Han L, Wang J, Liu G.
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
A framework for complex signal processing via synthetic biological operational amplifiers. [PDF]
Cao W, Liu L, Sun Q, Shan Y, Chen Y.
europepmc +1 more source

